China Jo-Jo Drugstores, Inc.

    China Jo-Jo Drugstores, Inc.

    NNASDAQ:CJJD
    1.05
    USD
    0.00
    (0.00%)
    2012 Y
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    TTM
    Revenue per Share
    1,668.93
    1,581.58
    1,143.89
    1,233.59
    1,327.99
    959
    913.85
    892.03
    857.73
    783.52
    944.97
    291.89
    107
    842.85
    Basic EPS, GAAP
    144.01
    -253.31
    -438.44
    13.74
    6.67
    -66.42
    -162.21
    -7.68
    -42.5
    -47.79
    -18.35
    -41.46
    -2.93
    -51.41
    Free Cash Flow per Basic Share
    148.81
    -48.03
    -24.71
    -32.01
    34.82
    13.51
    -47.28
    -107.09
    -67.2
    -3.92
    -32.72
    -7.05
    -2.82
    -4.22
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    556.16
    302.35
    -142.59
    -118.53
    -103.47
    -147.98
    -281.75
    -253.45
    -265.87
    -264.25
    -276.45
    -135.32
    -50.61
    -284.26
    Tangible Book Value per Share
    876.17
    652.91
    221.23
    226.06
    244.34
    281.84
    140.78
    101
    104.81
    117.81
    105.58
    25.07
    7.37
    126.73
    Basic Weighted Avg Shares
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1
    1
    - -
    Sales/Revenue/Turnover
    94
    89
    66
    77
    89
    81
    96
    108
    117
    133
    164
    149
    155
    133
    Operating Margin (%)
    11.11
    -14.06
    -29.07
    2.22
    -0.03
    -4.88
    -17.1
    -0.81
    -5.43
    -6.47
    -1.55
    -14.06
    -2.29
    -6.47
    Depreciation Expense
    2
    3
    3
    3
    1
    1
    1
    2
    2
    2
    1
    1
    5
    2
    Net Income, GAAP
    8
    -14
    -25
    1
    - -
    -6
    -17
    -1
    -6
    -8
    -3
    -21
    -4
    -8
    Effective Tax Rate (%)
    24.55
    - -
    - -
    6.29
    17.79
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    8.63
    -16.02
    -38.33
    1.11
    0.5
    -6.93
    -17.75
    -0.86
    -4.95
    -6.1
    -1.94
    -14.2
    -2.74
    -6.1
    Working Capital
    25
    15
    -4
    - -
    5
    16
    8
    1
    4
    7
    1
    -2
    -5
    7
    LT Debt
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    23
    17
    9
    8
    6
    17
    Total Equity
    52
    38
    14
    17
    19
    27
    19
    17
    19
    24
    23
    17
    14
    24
    Return on Invested Capital (%)
    15.34
    - -
    - -
    6.62
    -0.06
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    26.41
    - -
    - -
    20.16
    6.01
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    29.74
    -59.05
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -

    Capital Structure

    USD

    •

    in mil. unless spec.
    Sep'21
    Dec'21
    Mar'21
    ST Debt
    29
    32
    30
    LT Borrowings
    3
    3
    2
    LT Finance Leases
    17
    18
    15
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    - -
    - -
    - -
    Market Capitalization
    34
    38
    42

    Working Capital

    USD

    •

    in mil. unless spec.
    Sep'21
    Dec'21
    Mar'21
    Total Current Assets
    68
    63
    72
    Cash, Cash Equivalents & STI
    22
    12
    22
    Accounts Receivable, Net
    10
    12
    13
    Inventories
    13
    15
    17
    Total Current Liabilities
    58
    56
    65
    Payables & Accruals
    28
    23
    34
    ST Debt
    29
    32
    30
    Deferred Revenue
    1
    1
    1

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    2.36%
    -1.43%
    -14.24%
    Free Cash Flow
    0.76%
    121.83%
    13.46%
    Net Income, GAAP
    -41.69%
    197.77%
    -79.97%
    Sales/Revenue/Turnover
    9.38%
    8.08%
    3.85%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    164
    2023
    - -
    - -
    - -
    - -
    149
    2024
    - -
    - -
    - -
    - -
    155

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    -18.35
    2023
    - -
    - -
    - -
    - -
    -41.46
    2024
    - -
    - -
    - -
    - -
    -2.93

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business

    Company News

    Company News APIChatGPT

    • prnewswire.com

      China Jo-Jo Drugstores Announces Strategic Business Restructuring to Strengthen Wholesale Business for Greater Profitability and Growth

    • prnewswire.com

      China Jo-Jo Drugstores Reports Fiscal Year 2024 Financial Results

    • prnewswire.com

      China Jo-Jo Drugstores Announces $3.37 Million Registered Direct Offering

    • prnewswire.com

      China Jo-Jo Drugstores Announces Changes to Board of Directors

    • prnewswire.com

      China Jo-Jo Drugstores Announces $2.74 Million Registered Direct Offering

    • prnewswire.com

      China Jo-Jo Drugstores Announces $1.53 Million Registered Direct Offering

    • prnewswire.com

      China Jo-Jo Drugstores Regains Compliance with Nasdaq Minimum Bid Price Requirement

    • prnewswire.com

      China Jo-Jo Drugstores, Inc. Announces 1-for-20 Reverse Stock Split

    • prnewswire.com

      China Jo-Jo Drugstores Granted A Second Extension to Meet Nasdaq Minimum Bid Price Requirement

    • prnewswire.com

      China Jo-Jo Drugstores Announces Celebration of its 20th Anniversary

    • prnewswire.com

      China Jo-Jo Drugstores Announces $2.59 Million Registered Direct Offering

    • marketwatch.com

      Small-cap Chinese stocks spark meme-like buzz

    • benzinga.com

      Top 4 Risk Off Stocks That Are Preparing To Pump This Month

    • invezz.com

      China Jo-Jo Drugstores stock: Avoid this dilution machine

    • pennystocks.com

      Penny Stock Risk Assessment: Evaluating Potential Investments

    • investorplace.com

      3 Investors Betting Big on China Jo-Jo Drugstores (CJJD) Stock

    • prnewswire.com

      China Jo-Jo Drugstores Announces $7 Million Registered Direct Offering

    • pennystocks.com

      4 Low Float Penny Stocks To Watch This Week

    • prnewswire.com

      China Jo-Jo Drugstores Selected as one of the First Batch of Four-star Livelihood Pharmaceutical Service Stations in Hangzhou

    • prnewswire.com

      China Jo-Jo Drugstores Reports Fiscal Year 2021 Financial Results